PTGS2 and breast carcinoma: COX-2 overexpression in MDA-MB231 breast cancer cells and MCF10A breast epithelial cells has also been correlated with increased IL-8 expression and COX-2 antagonists such as NS-398 have been shown to down-regulate IL-8[30].